These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 31595793)
1. The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study. Bar-Sela G; Zalman D; Semenysty V; Ballan E Integr Cancer Ther; 2019; 18():1534735419881498. PubMed ID: 31595793 [No Abstract] [Full Text] [Related]
2. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the Cannabis-In-Cachexia-Study-Group. ; Strasser F; Luftner D; Possinger K; Ernst G; Ruhstaller T; Meissner W; Ko YD; Schnelle M; Reif M; Cerny T J Clin Oncol; 2006 Jul; 24(21):3394-400. PubMed ID: 16849753 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of Cannabis in Cancer Cachexia-Anorexia Syndrome. Reuter SE; Martin JH Clin Pharmacokinet; 2016 Jul; 55(7):807-812. PubMed ID: 26883879 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of Yukgunja-Tang for treating anorexia in patients with cancer: The protocol for a pilot, randomized, controlled trial. Kang HJ; Jeong MK; Park SJ; Jun HJ; Yoo HS Medicine (Baltimore); 2019 Oct; 98(40):e16950. PubMed ID: 31577697 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Use of Δ9-THC and Cannabidiol: Evaluation of a New Extraction Procedure for the Preparation of Cannabis-based Olive Oil. Morini L; Porro G; Liso M; Groppi A Curr Pharm Biotechnol; 2017; 18(10):828-833. PubMed ID: 29189144 [TBL] [Abstract][Full Text] [Related]
7. Prospective randomised trial of two dose levels of megestrol acetate in the management of anorexia-cachexia syndrome in patients with metastatic cancer. Gebbia V; Testa A; Gebbia N Br J Cancer; 1996 Jun; 73(12):1576-80. PubMed ID: 8664133 [TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled study about the effects of cannabidiol (CBD) on the pharmacokinetics of Delta9-tetrahydrocannabinol (THC) after oral application of THC verses standardized cannabis extract. Nadulski T; Pragst F; Weinberg G; Roser P; Schnelle M; Fronk EM; Stadelmann AM Ther Drug Monit; 2005 Dec; 27(6):799-810. PubMed ID: 16306858 [TBL] [Abstract][Full Text] [Related]
9. A randomised controlled trial of vaporised Δ Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105 [TBL] [Abstract][Full Text] [Related]
10. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. Jatoi A; Windschitl HE; Loprinzi CL; Sloan JA; Dakhil SR; Mailliard JA; Pundaleeka S; Kardinal CG; Fitch TR; Krook JE; Novotny PJ; Christensen B J Clin Oncol; 2002 Jan; 20(2):567-73. PubMed ID: 11786587 [TBL] [Abstract][Full Text] [Related]
11. Megestrol acetate for the treatment of anorexia-cachexia syndrome. Berenstein EG; Ortiz Z Cochrane Database Syst Rev; 2005 Apr; (2):CD004310. PubMed ID: 15846706 [TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. Loprinzi CL; Kugler JW; Sloan JA; Mailliard JA; Krook JE; Wilwerding MB; Rowland KM; Camoriano JK; Novotny PJ; Christensen BJ J Clin Oncol; 1999 Oct; 17(10):3299-306. PubMed ID: 10506633 [TBL] [Abstract][Full Text] [Related]
13. Brief versions of the FACIT-fatigue and FAACT subscales for patients with non-small cell lung cancer cachexia. Salsman JM; Beaumont JL; Wortman K; Yan Y; Friend J; Cella D Support Care Cancer; 2015 May; 23(5):1355-64. PubMed ID: 25351456 [TBL] [Abstract][Full Text] [Related]
14. The role of thalidomide and placebo for the treatment of cancer-related anorexia-cachexia symptoms: results of a double-blind placebo-controlled randomized study. Yennurajalingam S; Willey JS; Palmer JL; Allo J; Del Fabbro E; Cohen EN; Tin S; Reuben JM; Bruera E J Palliat Med; 2012 Oct; 15(10):1059-64. PubMed ID: 22880820 [TBL] [Abstract][Full Text] [Related]
15. Megestrol acetate for treatment of anorexia and cachexia associated with human immunodeficiency virus infection. Von Roenn JH; Murphy RL; Wegener N Semin Oncol; 1990 Dec; 17(6 Suppl 9):13-6. PubMed ID: 2259923 [TBL] [Abstract][Full Text] [Related]
16. An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. Brady CM; DasGupta R; Dalton C; Wiseman OJ; Berkley KJ; Fowler CJ Mult Scler; 2004 Aug; 10(4):425-33. PubMed ID: 15327041 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of mirtazapine for cancer-related cachexia and anorexia. Riechelmann RP; Burman D; Tannock IF; Rodin G; Zimmermann C Am J Hosp Palliat Care; 2010 Mar; 27(2):106-10. PubMed ID: 19776373 [TBL] [Abstract][Full Text] [Related]
18. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group. Loprinzi CL; Ellison NM; Goldberg RM; Michalak JC; Burch PA Semin Oncol; 1990 Dec; 17(6 Suppl 9):8-12. PubMed ID: 2259930 [TBL] [Abstract][Full Text] [Related]
19. Current and future care of patients with the cancer anorexia-cachexia syndrome. Del Fabbro E Am Soc Clin Oncol Educ Book; 2015; ():e229-37. PubMed ID: 25993178 [TBL] [Abstract][Full Text] [Related]
20. A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer-associated anorexia. Nelson K; Walsh D; Deeter P; Sheehan F J Palliat Care; 1994; 10(1):14-8. PubMed ID: 8035251 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]